First Wave BioPharma
First Wave BioPharma, formerly AzurRx, is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.

Year Established: 2014
Stock Ticker: FWBI
Exchange: NASDAQ